Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  MorphoSys AG    MOR

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
70.4(c) 72.54(c) 73.31(c) 72.26(c) 73.57 Last
286 462 182 104 83 586 91 022 64 297 Volume
-5.72% +3.04% +1.06% -1.43% +1.81% Change
More quotes
Financials (€)
Sales 2015 104 M
EBIT 2015 12,7 M
Net income 2015 1,81 M
Finance 2015 237 M
Yield 2015 -
Sales 2016 60,8 M
EBIT 2016 -4,78 M
Net income 2016 -9,44 M
Finance 2016 234 M
Yield 2016 -
PER 2015 174,25
PER 2016
EV / Sales 2015 16,1x
EV / Sales 2016 27,6x
Capitalization 1 913 M
More Financials
Company
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications.It operates through the following segments: Partnered Discovery, Proprietary Development, and AbD Serotec.The Partnered Discovery segment involves technologies for the generation of human... 
More about the company
Surperformance© ratings of MorphoSys AG
Trading Rating : Investor Rating :
More Ratings
Latest news on MORPHOSYS AG
07/30 MORPHOSYS : Partner Heptares Initiates Proprietary Therapeutic Antibody Program ..
07/30 MORPHOSYS : Partner Heptares Initiates Proprietary Therapeutic Antibody Program ..
07/27 MORPHOSYS : AG Reports Results for the First Six Months of 2015
07/24 MORPHOSYS : Announces Clinical Milestone in Blood Disorders Program
07/23 MORPHOSYS : Announces Clinical Milestone in Blood Disorders Program
07/21 MORPHOSYS : to Host Q2 2015 Conference Call on 27 July 2015
07/20 MORPHOSYS : to Host Q2 2015 Conference Call on 27 July 2015
06/01 MORPHOSYS : Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in ..
More news
Sector news : Biotechnology & Medical Research - NEC
08:02a QUINTILES TRANSNATIONAL : Announces Pricing of Secondary Public Offering
07/30 SEATTLE GENETICS : reports 2Q loss
07/30 QUINTILES TRANSNATIONAL : Announces Launch of Secondary Public Offering of Commo..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
07/27 MorphoSys' (MPSYF) CEO Simon Moroney on Q2 2015 Results - Earnings Call Trans..
07/21 MORPHOSYS : Dozens Of Partnerships And Self-Funded Growth
05/05 MorphoSys's (MPSYF) CEO Seth Fischer on Q1 2015 Results - Earnings Call Trans..
04/17 CELGENE : A Pre-Earnings Discussion Based On Recent News
02/26 MorphoSys' (MPSYF) CEO Simon Moroney on Q4 2014 Results - Earnings Call Trans..


Comments 
Advertisement
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MOR | DE0006632003 | 4-Traders
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions